<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0417625</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2839</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Tissue Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Tissue Res.</journal-id>
<journal-title-group>
<journal-title>Cell and tissue research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0302-766X</issn>
<issn pub-type="epub">1432-0878</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29079884</article-id>
<article-id pub-id-type="pmc">6029980</article-id>
<article-id pub-id-type="doi">10.1007/s00441-017-2713-x</article-id>
<article-id pub-id-type="manuscript">NIHMS972229</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling neurological diseases using iPSC-derived neural cells</article-title>
<subtitle>iPSC modeling of neurological diseases</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chao</surname>
<given-names>Jianfei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Yanhong</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Division of Stem Cell Biology, Department of Developmental and Stem Cell Biology, Beckman Research Institute of City of Hope, Duarte, CA91010, USA</aff>
<aff id="A2">
<label>2</label>Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence: <email>yshi@coh.org</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>371</volume>
<issue>1</issue>
<fpage>143</fpage>
<lpage>151</lpage>
<!--elocation-id from pubmed: 10.1007/s00441-017-2713-x-->
<abstract>
<p id="P1">Developing efficient models for neurological diseases enables us to uncover disease mechanisms and develop therapeutic strategies to treat them. Discovery of reprogramming somatic cells to induced pluripotent stem cells (iPSCs) has revolutionized the way of modeling human diseases, especially neurological diseases. Currently almost all types of neural cells, including but not limited to neural stem cells, neurons, astrocytes, oligodendrocytes and microglia, can be derived from iPSCs following developmental principles. These iPSC-derived neural cells provide valuable tools for studying neurological disease mechanisms, developing potential therapies, and deepening our understanding of the nervous system.</p>
</abstract>
<kwd-group>
<kwd>iPSC</kwd>
<kwd>neurological diseases</kwd>
<kwd>disease modeling</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>